Altered expression of circadian clock genes during peripheral blood stem cell mobilization induced by granulocyte colony-stimulating factor

被引:7
|
作者
Sugiyama, Akiko [1 ]
Yujiri, Toshiaki [1 ]
Tanaka, Mayumi [1 ]
Tanaka, Yoshinori [1 ]
Nakamura, Yukinori [1 ]
Tanizawa, Yukio [1 ]
机构
[1] Yamaguchi Univ, Grad Sch Med, Dept Biosignal Anal, Ube, Yamaguchi 7558505, Japan
关键词
Circadian clock; granulocyte colony-stimulating factor; noradrenaline; peripheral blood stem cell mobilization; BONE-MARROW; CD34(+) CELLS; OSCILLATIONS; MECHANISMS; IMMUNITY; RELEASE; MAMMALS; SIGNALS;
D O I
10.3109/07420528.2015.1053910
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Circulating hematopoietic stem cells exhibit robust circadian fluctuations, which influence the mobilized cell yield, even during enforced stem cell mobilization. However, alterations in the expression of circadian clock genes during granulocyte colony-stimulating factor (G-CSF)-induced peripheral blood stem cell (PBSC) mobilization are not fully elucidated. Therefore, we measured the expression of these genes in human peripheral blood leukocytes from 21 healthy donors. While CRY1 mRNA expression significantly increased by 3.9-fold (p < 0.01), the expression of PER3, CRY2 and BMAL1 mRNAs significantly decreased (by 0.2-fold, 0.2-fold, and 0.6-fold, respectively; p < 0.001) after G-CSF administration. Moreover, CRY1 mRNA expression was inversely correlated with the plasma level of noradrenaline (r = -0.36, p < 0.05), while PER3, CRY2, and BMAL1 mRNA expression directly correlated with the plasma level of noradrenaline (r = 0.55, r = 0.66, and r = 0.57, respectively; p < 0.001). Thus, significant correlations between the levels of circadian clock gene mRNAs and the plasma level of noradrenaline, a sympathetic nervous system neurotransmitter, were established. The modulation of sympathetic activation and of the circadian clock may be novel therapeutic targets for increasing stem cell yields in PBSC donors.
引用
收藏
页码:934 / 941
页数:8
相关论文
共 50 条
  • [21] Characterization of peripheral blood stem cell grafts mobilized by granulocyte colony-stimulating factor and plerixafor compared with granulocyte colony-stimulating factor alone
    Gaugler, Beatrice
    Arbez, Jessy
    Legouill, Steven
    Tiberghien, Pierre
    Moreau, Philippe
    Derenne, Sophie
    Saas, Philippe
    Mohty, Mohamad
    CYTOTHERAPY, 2013, 15 (07) : 861 - 868
  • [22] Peripheral Blood Stem Cell Mobilization in Healthy Donors by Granulocyte Colony-Stimulating Factor Causes Preferential Mobilization of Lymphocyte Subsets
    Melve, Guro Kristin
    Ersvaer, Elisabeth
    Eide, Geir Egil
    Kristoffersen, Einar K.
    Bruserud, Oystein
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [23] Acute glomerulonephritis in a donor as a side effect of allogeneic peripheral blood stem cell mobilization with granulocyte colony-stimulating factor
    Nasilowska-Adamska, B.
    Perkowska-Ptasinska, A.
    Tomaszewska, A.
    Serwacka, A.
    Marianska, B.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 92 (05) : 765 - 768
  • [24] Acute glomerulonephritis in a donor as a side effect of allogeneic peripheral blood stem cell mobilization with granulocyte colony-stimulating factor
    B. Nasilowska-Adamska
    A. Perkowska-Ptasinska
    A. Tomaszewska
    A. Serwacka
    B. Marianska
    International Journal of Hematology, 2010, 92 : 765 - 768
  • [25] Spleen enlargement following recombinant human granulocyte colony-stimulating factor administration for peripheral blood stem cell mobilization
    Picardi, M
    De Rosa, G
    Selleri, C
    Scarpato, N
    Soscia, E
    Martinelli, V
    Ciancia, R
    Rotoli, B
    HAEMATOLOGICA, 2003, 88 (07) : 794 - 800
  • [26] Transient glomerulonephritis as a side effect of peripheral blood stem cell mobilization with granulocyte colony-stimulating factor in the healthy donor
    Nasilowska-Adamska, B.
    Tomaszewska, A.
    Marianska, B.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S385 - S385
  • [27] Successful peripheral blood stem cell harvesting with granulocyte colony-stimulating factor alone after previous mobilization failure
    Lefrère, F
    Lévy, V
    Makke, J
    Audat, F
    Covozzano-Calvo, M
    Micléa, JM
    HAEMATOLOGICA, 2004, 89 (12) : 1532 - 1534
  • [28] Plasma stromal cell-derived factor-1 is not elevated during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization.
    Kozuka, T
    Ishimaru, F
    Fujii, K
    Nakase, K
    Tabayashi, T
    Tanimoto, N
    Harada, M
    BLOOD, 2001, 98 (11) : 331B - 331B
  • [29] Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma
    Arora, M
    Burns, LJ
    Barker, JN
    Miller, JS
    Defor, TE
    Olujohungbe, AB
    Weisdorf, DJ
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (06) : 395 - 404
  • [30] Use of thrombopoietin in combination with chemotherapy and granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization
    Gajewski, JL
    Rondon, G
    Donato, ML
    Anderlini, P
    Korbling, M
    Ippoliti, C
    Benyunes, M
    Miller, LL
    LaTemple, D
    Jones, D
    Ashby, M
    Hellmann, S
    Durett, A
    Lauppe, J
    Geisler, D
    Khouri, IF
    Giralt, SA
    Andersson, B
    Ueno, NT
    Champlin, R
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2002, 8 (10) : 550 - 556